Interleukin: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 29: | Line 29: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | |||
*IL-1 α | |||
[[2ila]] - hIL-1 α - human<BR /> | **[[2ila]] - hIL-1 α - human<BR /> | ||
[[2kki]] - hIL-1 α residues 121-271 <BR /> | **[[2kki]] - hIL-1 α residues 121-271 <BR /> | ||
[[2l5x]] – hIL-1 α residues 121-271 + calcium-binding protein A13 – NMR<BR /> | **[[2l5x]] – hIL-1 α residues 121-271 + calcium-binding protein A13 – NMR<BR /> | ||
*IL-1 β | |||
[[2wry]] - cIL-1 β – chicken<BR /> | **[[2wry]] - cIL-1 β – chicken<BR /> | ||
[[3nj5]] – cIL-1 β (mutant) <BR /> | **[[3nj5]] – cIL-1 β (mutant) <BR /> | ||
[[2nvh]], [[9ilb]], [[1iob]], [[5i1b]], [[2i1b]], [[4i1b]], [[1i1b]] - hIL-1 β | **[[2nvh]], [[9ilb]], [[1iob]], [[5i1b]], [[2i1b]], [[4i1b]], [[1i1b]] - hIL-1 β | ||
[[1tp0]], [[1t4q]], [[1too]], [[1twe]], [[1twm]], [[1s0l]], [[1l2h]], [[1hib]], [[21bi]], [[31bi]], [[41bi]] - hIL-1 β (mutant) <BR /> | **[[1tp0]], [[1t4q]], [[1too]], [[1twe]], [[1twm]], [[1s0l]], [[1l2h]], [[1hib]], [[21bi]], [[31bi]], [[41bi]] - hIL-1 β (mutant) <BR /> | ||
[[6i1b]], [[7i1b]] - hIL-1 β - NMR<BR /> | **[[6i1b]], [[7i1b]] - hIL-1 β - NMR<BR /> | ||
[[3ltq]] - hIL-1 β residues 117-269 <BR /> | **[[3ltq]] - hIL-1 β residues 117-269 <BR /> | ||
[[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> | **[[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> | ||
[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | **[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | ||
[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | **[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | ||
[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | **[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | ||
[[4g6j]], [[4g6m]] - hIL-1 β + antibody<br /> | **[[4g6j]], [[4g6m]] - hIL-1 β + antibody<br /> | ||
[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | **[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | ||
[[1md6]] – mIL-1F5 – mouse<BR /> | **[[1md6]] – mIL-1F5 – mouse<BR /> | ||
[[2mib]], [[8i1b]] - mIL-1 β | **[[2mib]], [[8i1b]] - mIL-1 β | ||
*IL-2 (T-cell growth factor) | |||
[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | **[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | ||
[[3qb1]] - hIL-2 (mutant)<br /> | **[[3qb1]] - hIL-2 (mutant)<br /> | ||
[[1irl]] – hIL-2 (mutant) - NMR<BR /> | **[[1irl]] – hIL-2 (mutant) - NMR<BR /> | ||
[[2erj]], [[2b5i]] - hIL-2 + IL-2 receptor α and β + cytokine receptor common γ<BR /> | **[[2erj]], [[2b5i]] - hIL-2 + IL-2 receptor α and β + cytokine receptor common γ<BR /> | ||
[[1z92]] - hIL-2 + IL-2 receptor α<BR /> | **[[1z92]] - hIL-2 + IL-2 receptor α<BR /> | ||
[[3qaz]] - hIL-2 + IL-2 receptor β and γ<BR /> | **[[3qaz]] - hIL-2 + IL-2 receptor β and γ<BR /> | ||
[[1qvn]], [[1nbp]], [[1m4a]], [[1m4b]] – hIL-2 (mutant) + inhibitor<BR /> | **[[1qvn]], [[1nbp]], [[1m4a]], [[1m4b]] – hIL-2 (mutant) + inhibitor<BR /> | ||
[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | **[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | ||
*IL-3 | |||
[[1jli]] – hIL-3 (mutant) – NMR<BR /> | **[[1jli]] – hIL-3 (mutant) – NMR<BR /> | ||
[[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR | **[[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR | ||
*IL-4 | |||
[[2b8u]], [[1hik]], [[2int]], [[1rcb]] – hIL-4<BR /> | **[[2b8u]], [[1hik]], [[2int]], [[1rcb]] – hIL-4<BR /> | ||
[[2cyk]], [[1cyl]], [[1itm]], [[1bbn]], [[1bcn]], [[1iti]], [[1itl]] – hIL-4 - NMR<BR /> | **[[2cyk]], [[1cyl]], [[1itm]], [[1bbn]], [[1bcn]], [[1iti]], [[1itl]] – hIL-4 - NMR<BR /> | ||
[[2b8x]], [[2b8y]], [[2b8z]], [[2b90]], [[2b91]], [[2d48]], [[1hzi]], [[1hij]] - hIL-4 (mutant) <BR /> | **[[2b8x]], [[2b8y]], [[2b8z]], [[2b90]], [[2b91]], [[2d48]], [[1hzi]], [[1hij]] - hIL-4 (mutant) <BR /> | ||
[[1iar]] - hIL-4 + IL-4 receptor α (mutant) <BR /> | **[[1iar]] - hIL-4 + IL-4 receptor α (mutant) <BR /> | ||
[[3bpl]] - hIL-4 + IL-4 receptor α + cytokine receptor common γ<BR /> | **[[3bpl]] - hIL-4 + IL-4 receptor α + cytokine receptor common γ<BR /> | ||
[[3qb7]] - hIL-4 + cytokine receptor common γ<BR /> | **[[3qb7]] - hIL-4 + cytokine receptor common γ<BR /> | ||
[[3bpn]] - hIL-4 + IL-4 receptor α + IL-13 receptor α | **[[3bpn]] - hIL-4 + IL-4 receptor α + IL-13 receptor α | ||
*IL-5 | |||
[[1hul]] – hIL-5<BR /> | **[[1hul]] – hIL-5<BR /> | ||
[[3b5k]] – mIL-5<br /> | **[[3b5k]] – mIL-5<br /> | ||
[[3qt2]] - hIL-5 + IL-5 receptor α (mutant) <BR /> | **[[3qt2]] - hIL-5 + IL-5 receptor α (mutant) <BR /> | ||
[[3va2]] - hIL-5 + IL-5 receptor α <BR /> | **[[3va2]] - hIL-5 + IL-5 receptor α <BR /> | ||
*IL-6 | |||
[[1alu]] – hIL-6<BR /> | **[[1alu]] – hIL-6<BR /> | ||
[[2l3y]] - mIL-6 residues 27-211 - NMR<br /> | **[[2l3y]] - mIL-6 residues 27-211 - NMR<br /> | ||
[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | **[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | ||
[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | **[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | ||
[[1i16]] – IL-6 + IL-6 receptor β - Herpesvirus 8<br /> | **[[1i16]] – IL-6 + IL-6 receptor β - Herpesvirus 8<br /> | ||
[[4j4l]] – hIL-6 + internalin B<BR /> | **[[4j4l]] – hIL-6 + internalin B<BR /> | ||
[[4ni7]], [[4ni9]] – hIL-6 + nucleotide aptamer<BR /> | **[[4ni7]], [[4ni9]] – hIL-6 + nucleotide aptamer<BR /> | ||
*IL-7 | |||
[[3di2]], [[3di3]] - hIL-7 residues 26-177 + IL-7 receptor α ectodomain | **[[3di2]], [[3di3]] - hIL-7 residues 26-177 + IL-7 receptor α ectodomain | ||
*IL-8 | |||
[[3il8]] – hIL-8<BR /> | **[[3il8]] – hIL-8<BR /> | ||
[[1il8]], [[2il8]] – hIL-8]- NMR<BR /> | **[[1il8]], [[2il8]] – hIL-8]- NMR<BR /> | ||
[[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> | **[[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> | ||
[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | **[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | ||
[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | **[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | ||
[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | ||
*IL-10 | |||
[[2h24]], [[1inr]], [[2ilk]], [[1ilk]] – hIL-10<BR /> | **[[2h24]], [[1inr]], [[2ilk]], [[1ilk]] – hIL-10<BR /> | ||
[[1j7v]] – hIL-10 + IL-10 receptor α (mutant) <BR /> | **[[1j7v]] – hIL-10 + IL-10 receptor α (mutant) <BR /> | ||
[[1y6k]] - hIL-10 residues 19-178 + IL-10 receptor α | **[[1y6k]] - hIL-10 residues 19-178 + IL-10 receptor α | ||
*IL-10 viral | |||
[[1vlk]] - hvIL-10 residues 26-170 - human herpesvirus 4<BR /> | **[[1vlk]] - hvIL-10 residues 26-170 - human herpesvirus 4<BR /> | ||
[[1y6m]] - hvIL-10 residues 26-170 + IL-10 receptor α <BR /> | **[[1y6m]] - hvIL-10 residues 26-170 + IL-10 receptor α <BR /> | ||
[[1y6n]] - hvIL-10 residues 26-170 (mutant) + IL-10 receptor α <BR /> | **[[1y6n]] - hvIL-10 residues 26-170 (mutant) + IL-10 receptor α <BR /> | ||
[[1lqs]] - hvIL-10 residues 20-176 + IL-10 receptor α - human herpesvirus 5<BR /> | **[[1lqs]] - hvIL-10 residues 20-176 + IL-10 receptor α - human herpesvirus 5<BR /> | ||
[[1lk3]] - hvIL-10 residues 26-175 + antibody | **[[1lk3]] - hvIL-10 residues 26-175 + antibody | ||
*IL-12 | |||
[[1f45]] - hIL-12 α and β (mutant) <BR /> | **[[1f45]] - hIL-12 α and β (mutant) <BR /> | ||
[[1f42]] - hIL-12 β P40 domain<BR /> | **[[1f42]] - hIL-12 β P40 domain<BR /> | ||
[[3hmx]] - hIL-12 α and β+ antibody<br /> | **[[3hmx]] - hIL-12 α and β+ antibody<br /> | ||
[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin | ||
*IL-13 | |||
[[1ijz]], [[1ik0]] – hIL-13 – NMR<BR /> | **[[1ijz]], [[1ik0]] – hIL-13 – NMR<BR /> | ||
[[1ga3]] - hIL-13 residues 21-132 - NMR<BR /> | **[[1ga3]] - hIL-13 residues 21-132 - NMR<BR /> | ||
[[3l5w]], [[3l5x]], [[3l5y]], [[3g6d]], [[4i77]], [[4ps4]] - hIL-13 residues 35-146 + antibody<BR /> | **[[3l5w]], [[3l5x]], [[3l5y]], [[3g6d]], [[4i77]], [[4ps4]] - hIL-13 residues 35-146 + antibody<BR /> | ||
[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | **[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | ||
[[3bpo]] - hIL-13 + IL-4 receptor α + IL-13 receptor α | **[[3bpo]] - hIL-13 + IL-4 receptor α + IL-13 receptor α | ||
*IL-15 | |||
[[2xqb]] – hIL-15 + antibody<BR /> | **[[2xqb]] – hIL-15 + antibody<BR /> | ||
[[2psm]], [[2z3q]], [[2z3r]] - hIL-15 + IL-15 receptor α<br /> | **[[2psm]], [[2z3q]], [[2z3r]] - hIL-15 + IL-15 receptor α<br /> | ||
[[4gs7]] - hIL-15 + IL-15 receptor α + IL-2 receptor β,γ <br /> | **[[4gs7]] - hIL-15 + IL-15 receptor α + IL-2 receptor β,γ <br /> | ||
*IL-16 | |||
[[1i16]] – hIL-16 - NMR<BR /> | **[[1i16]] – hIL-16 - NMR<BR /> | ||
[[1x6d]] – hIL-16 PDZ domain – NMR<BR /> | **[[1x6d]] – hIL-16 PDZ domain – NMR<BR /> | ||
*IL-17 | |||
[[4hr9]] - hIL-17A (mutant)<br /> | **[[4hr9]] - hIL-17A (mutant)<br /> | ||
[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | **[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | ||
[[2vxs]] - hIL-17A residues 20-255 + antibody<BR /> | **[[2vxs]] - hIL-17A residues 20-255 + antibody<BR /> | ||
[[1jpy]] – hIL-17F<BR /> | **[[1jpy]] – hIL-17F<BR /> | ||
[[3jvf]] - hIL-17F + IL-17 receptor α | **[[3jvf]] - hIL-17F + IL-17 receptor α | ||
*IL-18 (Interferon-γ inducing factor) | |||
[[1j0s]] – hIL-18 - NMR<BR /> | **[[1j0s]] – hIL-18 - NMR<BR /> | ||
[[4hjj]] - hIL-18 + antibody<br /> | **[[4hjj]] - hIL-18 + antibody<br /> | ||
[[2vxt]] - hIL-18 (mutant) + antibody<BR /> | **[[2vxt]] - hIL-18 (mutant) + antibody<BR /> | ||
[[3f62]] - hIL-18 residues 37-193 (mutant) + IL-18 binding protein<br /> | **[[3f62]] - hIL-18 residues 37-193 (mutant) + IL-18 binding protein<br /> | ||
[[4eee]], [[4ekx]] - hIL-18 (mutant) + 14L protein | **[[4eee]], [[4ekx]] - hIL-18 (mutant) + 14L protein | ||
*IL-19 | |||
[[1n1f]] – hIL-19 | **[[1n1f]] – hIL-19 | ||
*IL-20 | |||
[[4doh]] - hIL-20 + IL-20 receptor α,β <BR /> | **[[4doh]] - hIL-20 + IL-20 receptor α,β <BR /> | ||
*IL-21 | |||
[[2oqp]]– hIL-21 – NMR<BR /> | **[[2oqp]]– hIL-21 – NMR<BR /> | ||
[[3tgx]] - hIL-21 + IL-21 receptor α (mutant) <BR /> | **[[3tgx]] - hIL-21 + IL-21 receptor α (mutant) <BR /> | ||
*IL-22 | |||
[[1ykb]], [[1m4r]] – hIL-22<BR /> | **[[1ykb]], [[1m4r]] – hIL-22<BR /> | ||
[[3g9v]] - hIL-22 residues 29-179 + IL-22 receptor α2<BR /> | **[[3g9v]] - hIL-22 residues 29-179 + IL-22 receptor α2<BR /> | ||
[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | **[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | ||
[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody | **[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody | ||
*IL-23 | |||
[[3d87]] - hIL-23 α<BR /> | **[[3d87]] - hIL-23 α<BR /> | ||
[[3d85]] - hIL-23 α + antibody<BR /> | **[[3d85]] - hIL-23 α + antibody<BR /> | ||
[[4grw]] - hIL-23 α + + hIL-12 β + nanobody<BR /> | **[[4grw]] - hIL-23 α + + hIL-12 β + nanobody<BR /> | ||
[[3duh]] - hIL-23 α + hIL-12 β | **[[3duh]] - hIL-23 α + hIL-12 β | ||
*IL-28 | |||
[[3hhc]] – hIL-28B | **[[3hhc]] – hIL-28B | ||
*IL-29 | |||
[[3og4]], [[3og6]] – hIL-29 + IL-28 receptor α | **[[3og4]], [[3og6]] – hIL-29 + IL-28 receptor α | ||
*IL-33 | |||
**[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | |||
*IL-34 | |||
**[[4dkc]] - hIL-34<br /> | |||
**[[4exn]] - mIL-34<br /> | |||
[[4dkc]] - hIL-34<br /> | **[[4dkd]] - hIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> | ||
[[4exn]] - mIL-34<br /> | **[[4exp]] - mIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> | ||
[[4dkd]] - hIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> | **[[4dke]], [[4dkf]] - hIL-34 active core + antibody | ||
[[4exp]] - mIL-34 active core + macrophage colony-stimulating factor 1 receptor<br /> | }} | ||
[[4dke]], [[4dkf]] - hIL-34 active core + antibody | [[Category: Topic Page]] | ||
Revision as of 15:11, 27 November 2014
Template:STRUCTURE 2nvh
Interleukin (IL) is a cytokine which functions in the immune system. IL deficiency results in autoimmune disease. IL families are denoted by numbers.
- IL-1 is a group of 11 cytokines which regulate immune and inflammatory response. See Interleukin-1 beta.
- IL-2 is a cytokine made by leukocytes. It is used in cancer therapy to boost the immune system.
- IL-3 improves the body's natural response to disease by stimulating the differentiation of multipotent hematopoietic stem cells into myeloid or lymphoid progenitor cells.
- IL-4 induces the differentiation of naive helper T cells (Th0) to Th2 cells.
- IL-5 stimulates B cell growth and increases immunoglobulin secretion.
- IL-6 is both a pro-inflammatory cytokine and anti-inflammatory myokine.
- IL-7 is a cytokine important for B and T cells development.
- IL-8 induces chemotaxis and phagocytosis.
- IL-10 see Interleukin-10.
- IL-12 induces the differentiation of naive helper T cells (Th0) to Th1 cells.
- IL-13 induces the differentiation of naive helper T cells (Th0) to Th2 cells.
- IL-15 see Interleukin-15.
- IL-16 acts as chemoattractant, modulator of T cell activity and inhibitor of HIV replication.
- IL-17 recruits monocytes and neutrophils to the site of inflammation.
- IL-18 induces cell-mediated immunity following infection by microbial lipopolysaccharides.
- IL-19 induces activation of the signal transducer and activator of STAT3.
- IL-21 has potent effect on natural killer cells.
- IL-22 stimulates inflammatory responses like S100 and defensin.
- IL-23 induces activation of the signal transducer and activator of STAT4.
- IL-28 has a role in the immune defense against viruses.
- IL-29 similar to IL-28.
- IL-33 induces helper T cells, mast cells, eosinophils and basophils to produce type 2 cytokines.
- IL-34 increases growth or survival of monocytes.
3D structures of interleukin3D structures of interleukin
Updated on 27-November-2014